Research Article

Different Anatomical Subsites of Colon Cancer and Mortality: A Population-Based Study

Table 2

Univariate and multivariate analysis of overall and cancer-specific survival in patients with colon cancer.

VariableOverall survivalCancer-specific survival
UnivariateMultivariateUnivariateMultivariate
HR (95% CI)HR (95% CI)HR (95% CI)HR (95% CI)

Year of diagnosis
1973–1982ReferenceReferenceReferenceReference
1983–19920.88 (0.87, 0.89)<0.0010.87 (0.86, 0.89)<0.0010.82 (0.80, 0.83)<0.0010.82 (0.81, 0.84)<0.001
1993–20020.74 (0.73, 0.75)<0.0010.73 (0.72, 0.74)<0.0010.67 (0.66, 0.68)<0.0010.64 (0.63, 0.66)<0.001
2003–20120.59 (0.58, 0.59)<0.0010.62 (0.61, 0.63)<0.0010.54 (0.53, 0.55)<0.0010.52 (0.51, 0.53)<0.001
Age at diagnosis
<50 yReferenceReferenceReferenceReference
50–69 y1.34 (1.32, 1.37)<0.0011.48 (1.46, 1.51)<0.0011.02 (1.00, 1.04)0.0911.19 (1.17, 1.21)<0.001
≥70 y2.45 (2.41, 2.49)<0.0012.87 (2.82, 2.92)<0.0011.17 (1.15, 1.19)<0.0011.58 (1.55, 1.61)<0.001
Gender
MaleReferenceReferenceReferenceReference
Female0.93 (0.93, 0.94)<0.0010.81 (0.80, 0.81)<0.0010.93 (0.92, 0.94)<0.0010.89 (0.88, 0.90)<0.001
Race
WhiteReferenceReferenceReferenceReference
Black1.08 (1.07, 1.10)<0.0011.15 (1.13, 1.16)<0.0011.20 (1.18, 1.22)<0.0011.18 (1.17, 1.20)<0.001
Other (AP, AI/AN)0.77 (0.76, 0.78)<0.0010.86 (0.85, 0.88)<0.0010.84 (0.82, 0.85)<0.0010.91 (0.89, 0.93)<0.001
Primary site
RightReferenceReferenceReferenceReference
Left0.86 (0.85, 0.87)<0.0010.92 (0.92, 0.93)<0.0010.93 (0.92, 0.94)<0.0010.92 (0.91, 0.93)<0.001
Insurance status
InsuredReferenceReferenceReferenceReference
Uninsured1.21 (1.14,1.28)<0.0011.21 (1.15,1.28)<0.0011.43 (1.35, 1.52)<0.0011.11 (1.04, 1.18)<0.001
Marital status
UnmarriedReferenceReferenceReferenceReference
Married1.37 (1.36, 1.39)<0.0011.26 (1.25, 1.27)<0.0011.18 (1.17, 1.19)<0.0011.14 (1.12, 1.15)<0.001
Tumour stage
LocalizedReferenceReferenceReferenceReference
Regional1.59 (1.57, 1.60)<0.0011.62 (1.60, 1.63)<0.0013.34 (3.29, 3.40)<0.0013.22 (3.16, 3.27)<0.001
Distant6.60 (6.53, 6.67)<0.0016.99 (6.91, 7.08)<0.00117.98 (17.68, 18.28)<0.00116.98 (16.68, 17.29)<0.001
Tumour grade
IReferenceReferenceReferenceReference
II1.15 (1.14, 1.17)<0.0011.07 (1.06, 1.09)<0.0011.40 (1.37,1.43)<0.0011.16 (1.14, 1.18)<0.001
III1.75 (1.72, 1.78)<0.0011.38 (1.35, 1.40)<0.0012.54 (2.49, 2.60)<0.0011.64 (1.60, 1.67)<0.001
IV1.86 (1.78, 1.93)<0.0011.54 (1.48, 1.60)<0.0012.65 (2.53, 2.78)<0.0011.82 (1.73, 1.91)<0.001
Chemotherapy
YesReferenceReferenceReferenceReference
No0.83 (0.83, 0.84)<0.0011.13 (1.12, 1.15)<0.0011.85 (1.83, 1.87)<0.0011.06 (1.05, 1.07)<0.001
Surgery
YesReferenceReferenceReferenceReference
No4.41 (4.43, 4.49)<0.0012.59 (2.54, 2.63)<0.0015.42 (5.32, 5.52)<0.0012.62 (2.56, 2.67)<0.001
Radiation therapy
YesReferenceReferenceReferenceReference
No0.82 (0.80, 0.83)<0.0010.91 (0.90, 0.93)<0.0010.61 (0.59, 0.62)<0.0010.86 (0.84, 0.88)<0.001

I means well differentiated; II means moderately differentiated; III means poorly differentiated; IV means undifferentiated. AP: Asian or Pacific Islander; AI/AN: American Indian/Alaska Native.